Treatment of hyperprolactinemia in post-menopausal women: pros.

Abstract

The incidence of hyperprolactinemia in women peaks during the 3rd-4th decade and then greatly decreases after the menopause. Apart from the effects on the hypothalamic-pituitary-gonadal axis, prolactin can act directly on bone metabolism. Hyperprolactinemia is a recognized cause of secondary osteoporosis, and treatment with dopamine agonists can lead to… (More)
DOI: 10.1007/s12020-014-0377-9

Topics

Cite this paper

@article{Iacovazzo2015TreatmentOH, title={Treatment of hyperprolactinemia in post-menopausal women: pros.}, author={Donato Iacovazzo and Laura de Marinis}, journal={Endocrine}, year={2015}, volume={48 1}, pages={76-8} }